For more information or confidential assistance
800-306-3180
se habla español

Study Examines Testosterone Dosage and Heart Risks

Byetta pancreatic cancer patient
In July, researchers from the University of North Carolina at Chapel Hill published a study on testosterone heart risks in the medical journal, JAMA Internal Medicine, finding that the side effects of testosterone injections may pose the highest risk of cardiovascular events, hospitalizations and deaths. The team examined the comparative... Read more »

Does Testosterone Therapy Contribute to Atherosclerosis?

Byetta pancreatic cancer patient
The use of testosterone replacement therapy (TRT) has been increasing, yet some have expressed concerns about potentially life-threatening side effects of testosterone gels, creams, patches, and other products. Cardiovascular complications are of particular concern. Some men have filed lawsuits against a handful of TRT product manufacturers, claiming that the drugs... Read more »

Testosterone Injury Lawsuits Approach 2,000 Mark

The number of product liability complaints regarding testosterone replacement therapy continues to skyrocket, with allegations that the products caused heart attacks, stroke, and debilitating blood clot injuries. Men who took supplements such as Axiron, Testim and Androgel are seeking fair compensation and justice through the legal system, based on counts... Read more »

Is “Low T” a Real Condition? FDA Weighs In

Propecia erectile dysfunction patient
Over the past several years, the number of testosterone replacement therapy products prescribed to men approaching senior citizen status has literally soared – reaching sales topping $9 billion. The culprit? The apparent onset of the condition known as “low-t,” or low testosterone – a condition believed by some in the... Read more »

AndroGel Testosterone Lawsuits to Proceed as Planned

District Judge Matthew Kennelly, who is overseeing 1,500 AndroGel testosterone lawsuits in federal court, has denied a request by Abbvie, the manufacturer of AndroGel, to amend the schedule for a group of bellwether trials to be held in 2016 and 2017. Abbvie specifically requested that the court allow expert discovery and summary... Read more »

AbbVie Looking for Further Delay in AndroGel Lawsuits

Presently, there are over 800 AndroGel lawsuits pending against manufacturer AbbVie, all of which are seeking compensation for expenses and damages incurred as a result of alleged side effects linked to the testosterone therapy. These claims, which have been consolidated along with other lesser-known claims against testosterone replacement products, are awaiting... Read more »